News

Print

Product News and Articles

- of Articles PreviousPrevious Next Next

03/05/2021

Bio-Rad Expands Partnership with a Major Diagnostics Company to Provide InteliQ Portfolio Quality Controls

Bio-Rad has expanded its partnerships by providing InteliQ products and Unity QC data management solutions which helps efficiencies in workflow and improve laboratory analytical performance.
More

12/22/2020

Bio-Rad Expands Joint Marketing Agreement with Siemens Healthineers, Providing Quality Controls to Optimize Efficiency and Data Reliability

Bio-Rad expands joint marketing agreement with Siemens Healthineers, providing quality control products and data management solutions for Siemens Healthineers’ Atellica® platforms.
More

11/19/2020

Bio-Rad Granted Authorization to Sell or Import the Platelia SARS-CoV-2 Total Ab Test for COVID-19 Testing in Canada

Bio-Rad has announced that it has been granted authorization to sell or import the Platelia SARS-CoV-2 Total Ab test in Canada.
More

11/16/2020

Bio-Rad Adds New Features to the D-10 Hemoglobin Testing System

New features of the D-10 Hemoglobin Testing System better manages patient results, optimizes quality control, and more closely matches customer workflows and needs.
More

09/14/2020

Bio-Rad Launches VIROTROL SARS-CoV-2 and VIROCLEAR SARS-CoV-2, Serological Controls for COVID-19 Clinical Assay Testing

Bio-Rad announces the launch of its in vitro diagnostics VIROTROL SARS-CoV-2 and VIROCLEAR SARS-CoV-2 positive and negative quality controls for use in antibody testing of SARS-CoV-2, the virus associated with COVID-19.
More

06/18/2020

Bio-Rad Products Provide Support in the Fight against COVID-19

Bio-Rad continues to support the worldwide effort to fight SARS-CoV-2, the virus associated with COVID-19 disease, offering instruments, tests, and a SARS-CoV-2 standard to help labs validate COVID-19 assay results.
More

02/20/2020

Exact Diagnostics, a Bio-Rad Laboratories Company, Announces the Launch of EDX Respiratory Panel Control for Use with Molecular-Based Clinical Assays

Bio-Rad announced that Exact Diagnostics, a company that Bio-Rad acquired in the third quarter of 2019, has launched EDX RP Positive Run Control, an unassayed external quality control intended to monitor the performance
More

09/26/2019

VxWorks Vulnerabilities (URGENT/11)

Critical security vulnerabilities are reported in VxWorks real-time operating system. It is used in hardware instrumentation (patient monitors, industrial controllers, robotics, firewalls, routers, modems and printers).
More

05/22/2019

Bio-Rad Launches InteliQ, Load-and-Go Tubes for Quality Controls that Offer Enhanced Workflow Efficiencies

Bio-Rad announced the launch of InteliQ, a range of quality controls offered in a tube configuration that provides efficiencies in both workflow and data management.
More

01/29/2019

Bio-Rad Introduces Liquichek Serum Indices to Monitor an Instrument's Response to Detect HIL Specimen Interferences

Bio-Rad announced the availability of Liquichek Serum Indices that are used as part of laboratory interference testing to monitor an instrument’s ability to detect HIL specimen interferences in patient samples.
More

01/22/2019

Bio-Rad Launches qUAntify Advance Control for Urinalysis Testing

Bio-Rad announced the launch of qUAntify Advance Control for use in clinical labs performing urinalysis testing.
More

12/07/2018

Bio-Rad Quality Controls Now Available for Multiple Abbott Clinical Diagnostics Platforms

Bio-Rad announced expanded global access of the company’s quality controls across multiple Abbott clinical diagnostics platforms that now includes the Abbott Alinity ci-series instruments.
More

10/08/2018

Inpeco and Bio-Rad Partner to Connect Total Lab Automation Solution and Smart HPLC Technology

Inpeco and Bio-Rad announced their partnership to connect the Inpeco FlexLab track and the D-100 System to provide high-volume laboratories improved operational efficiencies to meet the growing worldwide demand for diabetes testing.
More

08/02/2017

Bio-Rad Launches Recombinant Luteinizing Hormone, Expanding its Critical Raw Materials Portfolio

Bio-Rad Launches Recombinant Luteinizing Hormone, Expanding its Critical Raw Materials Portfolio
More

07/28/2017

Bio-Rad Receives FDA Clearance to Aid in Diagnosing Diabetes with its D-10 Hemoglobin A1c Program

Bio-Rad Receives FDA Clearance to Aid in Diagnosing Diabetes with its D-10 Hemoglobin A1c Program
More

07/25/2017

Bio-Rad Signs Agreement with VISIA Imaging for Fully-Automated IFA Slide Processing and Reading System

Bio-Rad Signs Agreement with VISIA Imaging for Fully-Automated IFA Slide Processing and Reading System
More

07/24/2017

Bio-Rad Announces the Addition of Analytes for Liquichek Tumor Marker Control

Bio-Rad Announces the Addition of Analytes for Liquichek Tumor Marker Control
More

07/05/2017

Bio-Rad Announces FDA Clearance of its BioPlex 2200 ToRC IgM Assay

The BioPlex 2200 ToRC IgM Assay is a fully automated assay for the detection of IgM class antibodies to Toxoplasma gondii, rubella, and cytomegalovirus (CMV) offered in a multiplexed panel.
More

05/22/2017

Technical Support Update

Microsoft operating systems recently experienced a security vulnerability resulting from a widespread ransomware attack through Microsoft’s network environments on a global scale. Bio-Rad’s internal IT team has evaluated the technical details of the Microsoft security update and has approved the patch.
More

01/25/2017

Bio-Rad Launches Amplichek STI

Bio-Rad Launches Amplichek STI, the Third in a Series of Quality Controls for the Molecular Diagnostics Testing Market
More

11/22/2016

Bio-Rad Announces CE Marking of its BioPlex 2200 Syphilis Total & RPR Assay, a Novel Syphilis Testing Method

Bio-Rad Laboratories, Inc. today announced CE IVD marking for its BioPlex 2200 Syphilis Total & RPR assay, a novel universal testing method to aid in the diagnosis of syphilis infection.
More

10/24/2016

Bio-Rad Introduces its IH-1000 Blood Typing System for the U.S. Market

Bio-Rad Laboratories, Inc. today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its IH-1000 blood typing instrument along with approvals for a wide range of associated gel cards and reagents for the U.S. blood typing market.
More

08/03/2016

Amplichek I Quality Control

Bio-Rad Launches Amplichek I Quality Control, the Second in a Series of Controls for the Molecular Diagnostics Testing Market
More

06/06/2016

Liquichek™ Maternal Serum II Control

Bio-Rad Announces the Release of Liquichek™ Maternal Serum II Control. The Multi-Constituent Control Offers Increased Efficiency and Confidence in Test Results.
More

02/26/2016

Bio-Rad Announces CE IVD Marking of its QX200 Droplet Digital PCR System for Use as an In Vitro Diagnostic

Researchers can use the QX200 system for highly-accurate detection and quantification of nucleic acids, aiding clinical decision-making in the treatment of diseases ranging from cancer to transplant rejection and viral infection.
More

09/28/2015

Bio-Rad Unveils Critical Raw Material Antigens for Diagnostic Uses

Bio-Rad announced the launch of human recombinant protein antigens, which expand the company’s critical raw material offering.
More

08/25/2015

Bio-Rad Mission: Control™ Risk Management Software Launched at AACC in Atlanta

Bio-Rad Laboratories announced the launch of Bio-Rad Mission: Control™, the first objective risk management software to help laboratories identify the best QC rules and the right QC frequency to develop a customized quality control plan to deliver reliable test results.
More

06/16/2015

Important Information for Bio-Rad Customers in North America: Business Systems Update

Bio-Rad Laboratories will complete a business systems update on July 6. Impacts to business operations will be minimal, but North American customers should note that Bio-Rad will not ship products from July 1–July 5; shipping will resume on July 6. New customer account numbers and other changes to customer-facing data formats will also be implemented on this date.
More

11/21/2014

Geenius HIV-1/HIV-2 Supplemental Assay Press Release

Bio-Rad Laboratories' Geenius HIV-1/HIV-2 Supplemental Assay can differentiate circulating antibodies to Human Immunodeficiency Virus Types 1 and 2 in whole blood, serum and plasma. Earlier this month, the company announced that it received Premarket Application Approval from the U.S. Food and Drug Administration for the assay.
More

06/10/2014

Bio-Rad Extends Contract with Premier to Provide Quality Controls

Bio-Rad Laboratories announces that it has extended its contract with Premier, Inc., one of the largest group purchasing organizations based in the U.S.
More

05/29/2014

The Association for Talent Development Names Bio-Rad’s Quality Controls Customer Training Program a 2013 ‘Best Place to Learn’ Finalist

Bio-Rad Laboratories announced that its quality controls Customer Training program was named a ‘Best Place to Learn’ award Finalist by the Association for Talent Development (ATD), Dallas Chapter (formerly known as the American Society for Training and Development (ASTD).
More

01/22/2014

Bio-Rad Quality Controls Are Now Available in Dimension Vista Vials

Bio-Rad has announced a comprehensive line of multi-analyte quality controls now available in Siemens Dimension Vista® vials for use on Siemens Dimension Vista® Intelligent Lab Systems.
More

12/19/2013

Liquichek Maternal Serum 1st Trimester Control

Bio-Rad announces the launch of Liquichek Maternal Serum 1st Trimester Control
More

02/20/2013

Bio-Rad and Inpeco Announce Agreement to Connect Bio-Rad Diagnostic Platforms to Inpeco’s Total Lab Automation System

Inpeco, a leading company in the field of laboratory automation, has entered into a development agreement to build interfaces between Bio-Rad’s clinical diagnostics platforms for diabetes, autoimmune disease, and infectious disease testing and Inpeco’s FlexLab™ 3.6 system.
More

02/20/2013

Bio-Rad Laboratories Expands Their EQAS Offering with Three New Programs

Bio-Rad Laboratories announces the release of three External Quality Assurance Service (EQAS®) Programs for clinical laboratories and near patient/POC settings around the world. The new programs are: Cardiac Markers, Ethanol/Ammonia, and Lipids.
More

02/20/2013

Bio-Rad Laboratories launches the EQAS Coagulation Program

Bio-Rad Laboratories announced the release of External Quality Assurance Service (EQAS) Coagulation Program for clinical laboratories around the world.
More

02/20/2013

Bio-Rad Laboratories launches the EQAS Blood Gas Program

Bio-Rad Laboratories announced the release of its External Quality Assurance Service (EQAS) Blood Gas Program
More

01/17/2013

Bio-Rad Introduces EQAS Mobile

Bio-Rad Introduces EQAS Mobile, an Easy Way for Clinical Labs to Submit Proficiency Testing Results Using a Smartphone
More

01/17/2013

Bio-Rad Introduces Liquichek Whole Blood Immunosuppressant Control

This third party, human whole blood based product is designed for use as an assayed quality control material to monitor the precision of immunosuppressant drug testing procedures in the clinical laboratory.
More

08/31/2012

Bio-Rad Launches Liquichek Urine Toxicology Control, O Series

Bio-Rad Launches Liquichek Urine Toxicology Control, O Series
More

02/07/2012

Bio-Rad Launches My eInserts™, the First Internet-Based Tool for Customizing QC Insert Data

Bio-Rad announces My eInserts™, a free Internet-based tool that will allow Bio-Rad’s quality control (QC) customers to customize and view their product inserts at any time. My eInserts offers Bio-Rad's QC customers the option to customize their QC product insert data by selecting only the analytes, units, instruments, and/or methods they need.
More

12/13/2011

Siemens and Bio-Rad Extend Joint Marketing Agreement for IMMULITE and Dimension Systems to Further Optimize Efficiency and Data Reliability

Agreement extends clinical laboratories’ access to Bio-Rad’s consistent control product and data management tools within the Siemens clinical laboratory systems portfolio which, until today, were only available through Siemens’ ADVIA® Chemistry and ADVIA Centaur® Immunoassay systems.
More

03/08/2010

Liquichek Hematology and Reticulocyte Controls (A-I)

BIO-RAD Introduces Liquichek Hematology and Reticulocyte Controls for Abbott CELL-DYN Sapphire and CELL-DYN 4000 Instruments
More

03/05/2010

Liquichek Hematology and Reticulocyte Controls (S)

BIO-RAD Introduces Liquichek Hematology and Reticulocyte Controls for Siemens ADVIA Instruments.
More

01/06/2010

Bio-Rad Completes the Purchase of Certain Diagnostics Businesses of Biotest AG

Bio-Rad is pleased to expand its product offering in the area of immunohematology through the purchase of certain diagnostics businesses of Biotest AG.
More

07/15/2008

MRSASelect - Rapid Screening of MRSA

Bio-Rad's chromogenic test for rapid screening of MRSA now offers faster interpretation time.
More

02/11/2008

BioPlex 2200 Streamlines Vasculitis Testing

Novel automated multiplexing technology streamlines vasculitis testing, maximizes efficiency.
More

01/18/2008

Lyphochek Whole Blood Immunosuppressant Control

Bio-Rad announces the release of Lyphochek Whole Blood Immunosuppressant Control.
More

01/15/2008

Liquichek Microalbumin Control

Bio-Rad announces the launch of Liquichek Microalbumin Control for microalbumin testing.
More

01/07/2008

CandiSelect 4 Identifies Four Candida Species

Bio-Rad introduces a second chromogenic medium in the US for identification of four Candida species.
More

12/17/2007

Liquichek Diabetes Control

Bio-Rad announces the launch of Liquichek Diabetes Control for monitoring Hemoglobin A1C tests.
More

Sign Up for Bio-Rad Updates!
Enter your email address below to receive your choice of the latest news, promotions, and more.
Get Help